Silent α(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Chotani, Maqsood A ^a   Flavahan, Sheila ^a   Mitra, Srabani ^a   Daunt, David ^b   Flavahan, Nicholas A ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Medical Research Facility   (United States)

Author keywords

Microcirculation; Raynaud's Phenomenon; Scleroderma; Thermoregulation; Vascular smooth muscle

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; ALPHA 2C ADRENERGIC RECEPTOR; BRIMONIDINE; PHENYLEPHRINE;

ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SKIN BLOOD FLOW; SKIN BLOOD VESSEL;

EID: 0034094741     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.4.h1075     Document Type: Article

References (52)

1. Boege, F., M. Ward, R. Jurss, M. Hekman, and E. J. Helmreich. Role of glycosylation for beta 2-adrenoceptor function in A431 cells. J. Biol. Chem. 263: 9040-9049, 1988.
2. Bylund, D. B., D. C. Eikenberg, J. P. Hieble, S. Z. Langer, R. J. Lefkowitz, K. P. Minneman, P. B. Molinoff, R. R. Ruffolo, Jr., and U. Trendelenburg. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46: 121-136, 1994.
3. Cayla, C., S. Schaak, C. Roquelaine, C. Gales, F. Quinchon, and H. Paris. Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2. Br. J. Pharmacol. 126: 69-78, 1999.
4. Coffman, J. D., and R. A. Cohen. Alpha2-adrenergic and 5-HT2 receptor hypersensitivity in Raynaud's Phenomenon. J. Vasc. Med. Biol. 2: 100-106, 1990.
5. Coupry, I., E. Duzic, and S. M. Lanier. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. II. Preferential coupling of the alpha 2C-adrenergic receptor to the guanine nucleotide-binding protein, Go. J. Biol. Chem. 267: 9852-9857, 1992.
6. Daunt, D. A., C. Hurt, L. Hein, J. Kallio, F. Feng, and B. K. Kobilka. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol. Pharmacol. 51: 711-720, 1997.
7. Duzic, E., and S. M. Lanier. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. III. Coupling of alpha 2-adrenergic receptor subtypes in a cell type-specific manner. J. Biol. Chem. 267: 24045-24052, 1992.
8. Ekenvall, L., L. E. Lindblad, O. Norbeck, and B. M. Etzell. alpha-Adrenoceptors and cold-induced vasoconstriction in human finger skin. Am. J. Physiol. Heart Circ. Physiol. 255: H1000-H1003, 1988.
9. Faber, J. E. Effect of local tissue cooling on microvascular smooth muscle and postjunctional alpha 2-adrenoceptors. Am. J. Physiol. Heart Circ. Physiol. 255: H121-H130, 1988.
10. Faber, J. E. In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ. Res. 62: 37-50, 1988.
11. Fenrick, R., N. McNicoll, and A. De Lean. Glycosylation is critical for natriuretic peptide receptor-B function. Mol. Cell. Biochem. 165: 103-109, 1996.
12. Flavahan, N. A. The role of alpha2-adrenoceptors as cutaneous thermosensors. NIPS 6: 251-255, 1991.
13. Flavahan, N. A., J. P. Cooke, J. T. Shepherd, and P. M. Vanhoutte. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J. Pharmacol. Exp. Ther. 241: 361-365, 1987.
14. Flavahan, N. A., L. E. Lindblad, T. J. Verbeuren, J. T. Shepherd, and P. M. Vanhoutte. Cooling and alpha 1-and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am. J. Physiol. Heart Circ. Physiol. 249: H950-H955, 1985.
15. Flavahan, N. A., and J. C. McGrath. Blockage by yohimbine of prazosin-resistant pressor effects of adrenaline in the pithed rat. Br. J. Pharmacol. 69: 355-357, 1980.
16. Flavahan, N. A., and J. C. McGrath. Are human vascular alpha-adrenoceptors atypical? J. Cardiovasc. Pharmacol. 6: 208-210, 1984.
17. Flavahan, N. A., T. J. Rimele, J. P. Cooke, and P. M. Vanhoutte. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J. Pharmacol. Exp. Ther. 230: 699-705, 1984.
18. Flavahan, N. A., and P. M. Vanhoutte. Alphal-adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci. 7: 347-349, 1986.
19. Flavahan, N. A., and P. M. Vanhoutte. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 238: 131-138, 1986.
20. Flavahan, N. A., and P. M. Vanhoutte. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 238: 139-147, 1986.
21. Flavahan, N. A., and P. M. Vanhoutte. Heterogeneity of alpha-adrenergic responses in vascular smooth muscle: role of receptor subtypes and receptor-reserve. In: The Alpha1-Adrenoceptor, edited by R. R. Ruffolo, Jr. Clifton, NJ: Humana, 1987, p. 351-403.
22. Freedman, R. R., R. P. Baer, and M. D. Mayes. Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 92: 1448-1451, 1995.
23. Freedman, R. R., M. Moten, P. Migaly, and M. Mayes. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease. Arthritis Rheum. 36: 685-690, 1993.
24. Freedman, R. R., S. C. Sabharal, N. Desai, P. Wenig, and M. Mayes. Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease. Arthritis Rheum. 32: 61-65, 1989.
25. Freeman, J. E., W. Y. Kuo, B. Drenger, T. N. Barnett, M. A. Levine, and N. A. Flavahan. Analysis of lysophophatidylcholine-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 28: 345-352, 1996.
26. Harker, C. T., P. J. Ousley, C. J. Bowman, and J. M. Porter. Cooling augments alpha 2-adrenoceptor-mediated contractions in rat tail artery. Am. J. Physiol. Heart Circ. Physiol. 260: H1166-H1171, 1991.
27. Harker, C. T., and P. M. Vanhoutte. Cooling the central ear artery of the rabbit: myogenic and adrenergic responses. J. Pharmacol. Exp. Ther. 245: 89-93, 1988.
28. Harrison, J. K., D. D. D'Angelo, D. W. Zeng, and K. R. Lynch. Pharmacological characterization cf rat alpha 2-adrenergic receptors. Mol. Pharmacol. 40: 407-412 1991..
29. Jansson, C. C., K. Pohjanoksa, J. Lang, S. Wurster, J. M. Savola, and M. Scheinin. Alpha2-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner. Eur. J. Pharmacol. 374: 137-146, 1999.
30. Jasper, J. R., J. D. Lesnick, L. K. Chang, S. S. Yamanishi, T. K. Chang, S. A. Hsu, D. A. Daunt, D. W. Bonhaus, and R. M. Eglen. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-med ated [35S]GTPgammaS binding. Biochem. Pharmacol. 55: 1035-1043, 1998.
31. Jewell-Motz, E. A., and S. B. Liggett. G protein-coupled receptor kinase specificity for phosphorylation and desensitization of alpha2-adrenergic receptor subtypes. J. Biol. Chem. 271: 18082-18087, 1996.
32. 2+ elevation in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 287: 667-671, 1998.
33. Kurose, H., and R. J. Lefkowitz. Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. J. Biol. Chem. 269: 10093-10099, 1994.
34. Lanier, S. M., M. Lafontan, L. E. Limbird, and H. Paris. Summary of the ASPET-sponsored Colloquium: Alpha-2 adrenergic receptors: structure, function, and therapeutic implications, October 25-27, 1995. J. Pharmacol. Exp. Ther. 277: 10-16, 1996.
35. Leech, C. J., and J. E. Faber. Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. Heart Circ. Physlol. 270: H710-H722, 1996.
36. Lewis, T. Experiments relating to the peripheral mechanisms involved in spasmodic arrest of the circulation in fingers: a variety of Raynaud's disease. Heart 15: 7-101, 1929.
37. Lindblad, L. E., L. Ekenvall, B. M. Etzell, and S. Bevegard. Adrenoceptors in Raynaud's disease. J. Cardiovasc. Pharmacol. 14: 881-885, 1989.
38. Link, R., D. Daunt, G. Barsh, A. Chruscinski, and B. Kobilka. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol. Pharmacol. 42: 16-27, 1992.
39. Link, R. E., K. Desai, L. Hein, M E. Stevens, A. Chruscinski, D. Bernstein, G. S. Barsh, and B. K. Kobilka. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273: 803-805, 1996.
40. Liu, Q., and N. A. Flavahan. Hypoxic dilatation of porcine small coronary arteries: role of endothelium and KATP-channels. Br. J. Pharmacol. 120: 728-734, 1997.
41. MacDonald, E., B. K. Kobilka, and M. Scheinin. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol. Sci. 18: 211-219, 1997.
42. MacMillan, L. B., L. Hein, M. S. Smith, M. T. Piascik, and L. E. Limbird. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273: 801-803, 1996.
43. Ping, P., and J. E. Faber. Characterization of alpha-adrenoceptor gene expression in arterial and venous smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 265: H1501-H1509, 1993.
44. Rands, E., M. R. Candelore, A. H. Cheung, W. S. Hill, C. D. Strader, and R. A. Dixon. Mutational analysis of beta-adrenergic receptor glycosylation. J. Biol. Chem. 265: 10759-10764, 1990.
45. Rosin, D. L., E. M. Talley, A. Lee, R. L. Stornetta, B. D. Gaylinn, P. G. Guyenet, and K. R. Lynch. Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372: 135-165, 1996.
46. Stone, L. S., L. B. MacMillan, K F. Kitto, L. E. Limbird, and G. L. Wilcox. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J. Neurosci. 17: 7157-7165, 1997.
47. Tanila, H., K. Mustonen, J. Sallinen, M. Scheinin, and P. Riekkinen, Jr. Role of alpha2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alpha2C-adrenoceptor gene. Eur. J. Neurosci. 11: 599-603, 1999.
48. 3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B-and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur. J. Pharmacol. 343: 93-101, 1998.
49. 3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J. Pharmacol. Exp. Ther. 271: 1558-1565, 1994.
50. 3H]-MK912 binding delineates two alpha 2-adrenoceptor subtypes in rat CNS one of which is identical with the cloned pA2d alpha 2-adrenoceptor. Br. J. Pharmacol. 106: 986-995, 1992 (published erratum appears in Br. J. Pharmacol. 108: 852, 1993).
51. Vanhoutte, P. M. Physical factors of regulation. In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 16, p. 443-474.
52. Wigley, F. M., and N. A. Flavahan. Raynaud's phenomenon. Rheum. Dis. Clin. North Am. 22: 765-781, 1996.